{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:42:17Z","timestamp":1790066537490,"version":"4.0.1"},"reference-count":239,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The senescence of immune cells has also emerged as a key hallmark of immunological dysregulation and chronic inflammation in autoimmunity. Senescent immune cells are irreversibly arrested in the cell cycle, exhibit antimetabolic characteristics, and secrete pro-inflammatory mediators, all together disrupting immune homeostasis. T cells, B cells, and innate immune subsets, acquire a senescence-associated secretory phenotype (SASP), which initiates tissue damage and sustains continuous inflammation in autoimmune diseases. The accumulation of senescent immune cells undermines immune surveillance, disrupts self-tolerance mechanisms, and enhances autoantibody production, all of which contribute to the pathogenesis of autoimmune diseases, including type 1 diabetes (T1D), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). Accumulating evidence reveals that metabolic stress, chronic DNA damage, and persistent antigenic exposure in inflammatory microenvironments induce immune cell senescence. Such senescent condition more aggressively promotes disease pathogenesis by compromising antigen presentation, disrupting cytokine signaling, and weakening the function of regulatory T cells (Tregs). Targets of senolytic drugs, SASP inhibitors, monoclonal antibodies (mAbs), and CAR T cell therapy currently have the potential to accelerate autoimmune pathology. These treatments would be directed specifically against the selective elimination or reprogramming of senescent cells to restore immune homeostasis. This review examines the mechanistic relationships between autoimmune development and immune cell senescence, as well as recent advancements in senescence-directed therapy. Understanding these pathways can provide new insights into autoimmune pathogenesis and inform future therapeutic approaches to immune cell aging.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1596686","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:32Z","timestamp":1754544572000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting"],"prefix":"10.3389","volume":"16","author":[{"given":"Fei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100030","article-title":"Genomics and the multifactorial nature of human autoimmune disease","volume":"365","author":"Cho","year":"2011","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-024-01529-7","article-title":"Immunosenescence and age-related immune cells: causes of age-related diseases","volume":"48","author":"Kim","year":"2024","journal-title":"Arch Pharmacal Res"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13316","article-title":"Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells","volume":"20","author":"Zhou","year":"2021","journal-title":"Aging Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03547-7","article-title":"An aged immune system drives senescence and ageing of solid organs","volume":"594","author":"Yousefzadeh","year":"2021","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0034-8376(25)00212-8","article-title":"The role of immunosenescence in the development of age-related diseases","volume":"68","author":"F\u00fcl\u00f6p","year":"2016","journal-title":"Rev investigacion clinica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133679","article-title":"Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy","volume":"130","author":"Liu","year":"2020","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/ar974","article-title":"Ageing, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity\u2013catalysts of autoimmunity and chronic inflammation","volume":"5","author":"Goronzy","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1180","article-title":"Ageing, autoimmunity and arthritis: senescence of the B cell compartment\u2013implications for humoral immunity","volume":"6","author":"Johnson","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103409","article-title":"Senescent T cells: a potential biomarker and target for cancer therapy","volume":"68","author":"Zhang","year":"2021","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2981","article-title":"The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells","volume":"15","author":"Lanna","year":"2014","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301409","article-title":"IFN-\u03b1 inhibits telomerase in human CD8+ T cells by both hTERT downregulation and induction of p38 MAPK signaling","volume":"191","author":"Lanna","year":"2013","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3665","article-title":"A sestrin-dependent Erk\u2013Jnk\u2013p38 MAPK activation complex inhibits immunity during aging","volume":"18","author":"Lanna","year":"2017","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28\u2013 and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"Strioga","year":"2011","journal-title":"Immunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1189\/jlb.0208107","article-title":"The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression","volume":"85","author":"Chattopadhyay","year":"2009","journal-title":"J Leucocyte Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1042\/BST20150092","article-title":"CD8+ T-cell senescence: No role for mTOR","volume":"43","author":"Henson","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.3390\/ijms25052688","article-title":"Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111504","article-title":"B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1","volume":"209","author":"Karnowski","year":"2012","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar766","article-title":"The expansion of CD4+ CD28-T cells in patients with rheumatoid arthritis","volume":"5","author":"Pawlik","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01649-0","article-title":"Immunosenescence of T cells: a key player in rheumatoid arthritis","volume":"71","author":"Gao","year":"2022","journal-title":"Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq499","article-title":"Expansion of CD4+ CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus","volume":"32","author":"Giubilato","year":"2011","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200112516","article-title":"CD4+ CD28\u2013costimulation-independent T cells in multiple sclerosis","volume":"108","author":"Markovic-Plese","year":"2001","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9213-4","article-title":"Association of graves\u2019 Disease and prevalence of circulating IFN-\u03b3-producing CD28\u2013 T cells","volume":"28","author":"Sun","year":"2008","journal-title":"J Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.10.751","article-title":"CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener\u2019s granulomatosis","volume":"56","author":"Lamprecht","year":"2001","journal-title":"Thorax"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.21140","article-title":"T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis","volume":"52","author":"Sawai","year":"2005","journal-title":"Arthritis Rheumatism"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.006","article-title":"CX3CR1 drives cytotoxic CD4+ CD28\u2013 T cells into the brain of multiple sclerosis patients","volume":"38","author":"Broux","year":"2012","journal-title":"J autoimmunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/ijms18081742","article-title":"Markers of T cell senescence in humans","volume":"18","author":"Xu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.850031","article-title":"Accelerated telomere shortening in rheumatic diseases: cause or consequence","volume":"9","author":"Dehbi","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/09612033211038057","article-title":"Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus","volume":"30","author":"Handono","year":"2021","journal-title":"Lupus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502448","article-title":"Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients","volume":"197","author":"Claes","year":"2016","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128269","article-title":"Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response","volume":"10","author":"Adlowitz","year":"2015","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733566","article-title":"The dynamics of B cell aging in health and disease","volume":"12","author":"de Mol","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-020-00210-z","article-title":"Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination","volume":"17","author":"Frasca","year":"2020","journal-title":"Immun Ageing"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2010.00566.x","article-title":"Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age","volume":"9","author":"Lescale","year":"2010","journal-title":"Aging Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2617","article-title":"Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice","volume":"166","author":"Anspach","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00483","article-title":"Human B-1 cells and B-1 cell antibodies change with advancing age","volume":"10","author":"Rodriguez-Zhurbenko","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb0806","article-title":"IL-10\u2013producing Tfh cells accumulate with age and link inflammation with age-related immune suppression","volume":"6","author":"Almanan","year":"2020","journal-title":"Sci Adv"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/ijms22041839","article-title":"B cells with a senescent-associated secretory phenotype accumulate in the adipose tissue of individuals with obesity","volume":"22","author":"Frasca","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24013","article-title":"Adipocyte-derived inflammatory molecules induce senescent B cells through metabolic pathways","volume":"32","author":"Frasca","year":"2024","journal-title":"Obesity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700326104","article-title":"Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells","volume":"104","author":"Gray","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3109\/08923979409007097","article-title":"Cytotoxic Cs in immunodeficient athymic mice","volume":"16","author":"Budzynski","year":"1994","journal-title":"Immunopharmacol immunotoxicol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2012.04.008","article-title":"Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans","volume":"24","author":"Solana","year":"2012","journal-title":"Semin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0303097","article-title":"Cytokine requirements for the growth and development of mouse NK cells in vitro","volume":"74","author":"Toomey","year":"2003","journal-title":"J Leucocyte Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2009.03.002","article-title":"NK cells in the CD19\u2013 B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors","volume":"130","author":"King","year":"2009","journal-title":"Mech Ageing Dev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6","article-title":"CD4+, CD28\u2013 T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems","volume":"44","author":"Warrington","year":"2001","journal-title":"Arthritis Rheumatism"},{"key":"B54","article-title":"Premature immunosenescence in rheumatoid arthritis","volume":"29","author":"Weyand","year":"2002","journal-title":"J Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molimm.2009.02.023","article-title":"The role of the activating receptor NKG2D in autoimmunity","volume":"47","author":"Van Belle","year":"2009","journal-title":"Mol Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"109202","DOI":"10.1016\/j.clim.2022.109202","article-title":"T-cell senescence: A crucial player in autoimmune diseases","volume":"248","author":"Lu","year":"2023","journal-title":"Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/art.24556","article-title":"Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus","volume":"60","author":"Park","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000569","article-title":"Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus","volume":"186","author":"Huang","year":"2011","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.003","article-title":"IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice","volume":"53","author":"Hodge","year":"2014","journal-title":"J autoimmunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4138-7","article-title":"Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity","volume":"37","author":"Liu","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12117","article-title":"Human dendritic cell subsets","volume":"140","author":"Collin","year":"2013","journal-title":"Immunology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901022","article-title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response","volume":"184","author":"Panda","year":"2010","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9448-8","article-title":"Impaired functions of peripheral blood monocyte subpopulations in aged humans","volume":"30","author":"Nyugen","year":"2010","journal-title":"J Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-11-30","article-title":"Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults","volume":"11","author":"Seidler","year":"2010","journal-title":"BMC Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12854","article-title":"Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis","volume":"53","author":"Yang","year":"2020","journal-title":"Cell\u00a0proliferation"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-\u03b2gal) activity, a biomarker of senescent cells in culture and in vivo","volume":"4","author":"Debacq-Chainiaux","year":"2009","journal-title":"Nat Protoc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-019-0169-4","article-title":"Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype","volume":"16","author":"Del Rey","year":"2019","journal-title":"Immun Ageing"},{"key":"B69","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11696","article-title":"IFN-\u03b3\u2013dependent transcription of MHC class II IA is impaired in macrophages from aged mice","volume":"107","author":"Herrero","year":"2001","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri2634","article-title":"Transcriptional control of the inflammatory response","volume":"9","author":"Medzhitov","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700148","article-title":"Human monocyte subsets are transcriptionally and functionally altered in aging in response to pattern recognition receptor agonists","volume":"199","author":"Metcalf","year":"2017","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.18632\/oncotarget.23851","article-title":"Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5281358","DOI":"10.1155\/2017\/5281358","article-title":"NLRP3 inflammasome expression and signaling in human diabetic wounds and in high glucose induced macrophages","volume":"2017","author":"Zhang","year":"2017","journal-title":"J\u00a0Diabetes Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e13225","DOI":"10.1590\/1414-431x2024e13225","article-title":"Effects of immune exhaustion and senescence of innate immunity in autoimmune disorders","volume":"57","author":"Cunha","year":"2024","journal-title":"Braz J Med Biol Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649693","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different MO","volume":"12","author":"Fresneda Alarcon","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaut.2004.03.012","article-title":"NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells","volume":"23","author":"Stoffels","year":"2004","journal-title":"J autoimmunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxaf029","article-title":"Senolytic treatment to rescue hallmarks of senescence in lymph node fibroblasts from patients with rheumatoid arthritis: Implications for premature aging and potential therapeutic intervention in early rheumatoid arthritis","volume":"219","author":"de Jong","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-024-03278-2","article-title":"Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis","volume":"21","author":"Drake","year":"2024","journal-title":"J Neuroinflammation"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350603","article-title":"CD4+ CD57+ senescent T cells as promoters of systemic lupus erythematosus pathogenesis and the therapeutic potential of senolytic BCL-2 inhibitor","volume":"57","author":"Jiang","year":"2024","journal-title":"Eur J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802813","article-title":"The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity","volume":"182","author":"Bardwell","year":"2009","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"113132","DOI":"10.1016\/j.intimp.2024.113132","article-title":"Topical administration of a BCL-2 inhibitor alleviates cutaneous lupus erythematosus","volume":"142","author":"Jiang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.5","article-title":"Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL\/lpr mouse model of systemic lupus erythematosus","volume":"9","author":"Shimp","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S269725","article-title":"The HSP90 inhibitor, 17-AAG, influences the activation and proliferation of T lymphocytes via AKT\/GSK3\u03b2 signaling in MRL\/lpr mice","author":"Hong","year":"2020","journal-title":"Drug Design Dev Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2019","journal-title":"Front Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28906","article-title":"Geldanamycin induces apoptosis and inhibits inflammation in fibroblast-like synoviocytes isolated from rheumatoid arthritis patients","volume":"120","author":"Ma","year":"2019","journal-title":"J Cell Biochem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05579-w","article-title":"Modulation of TNFR 1-triggered two opposing signals for inflammation and apoptosis via RIPK 1 disruption by geldanamycin in rheumatoid arthritis","volume":"40","author":"Saeki","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/biom12081153","article-title":"Heat shock protein 90 (Hsp90) and Hsp70 as potential therapeutic targets in autoimmune skin diseases","volume":"12","author":"Tukaj","year":"2022","journal-title":"Biomolecules"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127361","article-title":"The HSP90 inhibitor ganetespib alleviates disease progression and augments intermittent cyclophosphamide therapy in the MRL\/lpr mouse model of systemic lupus erythematosus","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/art.24047","article-title":"Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis","volume":"58","author":"Rice","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"B92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.intimp.2015.11.030","article-title":"MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-\u03baB","volume":"30","author":"Zhang","year":"2016","journal-title":"Int immunopharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.01.003","article-title":"DNA induction of MDM2 promotes proliferation of human renal mesangial cells and alters peripheral B cells subsets in pediatric systemic lupus erythematosus","volume":"94","author":"Zhang","year":"2018","journal-title":"Mol Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopha.2018.02.040","article-title":"Quercetin and low level laser therapy promote wound healing process in diabetic rats via structural reorganization and modulatory effects on inflammation and oxidative stress","volume":"101","author":"Ahmed","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biopha.2017.03.026","article-title":"Therapeutic effect of quercetin in collagen-induced arthritis","volume":"90","author":"Haleagrahara","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666190206225034","article-title":"Potent inhibitory effects of quercetin on inflammatory responses of collagen-induced arthritis in mice","volume":"19","author":"Kawaguchi","year":"2019","journal-title":"Endocrine Metab Immune Disorders-Drug Targets (Formerly Curr Drug Targets-Immune Endocrine Metab Disorders)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.03.057","article-title":"Quercetin attenuates zymosan-induced arthritis in mice","volume":"102","author":"Guazelli","year":"2018","journal-title":"Biomed pharmacother"},{"key":"B98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/15384101.2017.1387701","article-title":"Dietary quercetin ameliorates experimental colitis in mouse by remodeling the function of colonic macrophages via a heme oxygenase-1-dependent pathway","volume":"17","author":"Ju","year":"2018","journal-title":"Cell Cycle"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960601","article-title":"Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis","volume":"13","author":"Ijima","year":"2022","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/0192623314526318","article-title":"Genistein protects female nonobese diabetic mice from developing type 1 diabetes when fed a soy-and alfalfa-free diet","volume":"43","author":"Guo","year":"2015","journal-title":"Toxicologic pathol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.12659\/MSM.909627","article-title":"Baicalin, a Chinese herbal medicine, inhibits the proliferation and migration of human non-small cell lung carcinoma (NSCLC) cells, A549 and H1299, by activating the SIRT1\/AMPK signaling pathway","volume":"24","author":"You","year":"2018","journal-title":"Med Sci monitor: Int Med J Exp Clin Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"268065","DOI":"10.1155\/2013\/268065","article-title":"Baicalin inhibits IL-17-mediated joint inflammation in murine adjuvant-induced arthritis","volume":"2013","author":"Yang","year":"2013","journal-title":"J Immunol Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6502","article-title":"Icariin prevents cytokine\u2212induced \u03b2\u2212cell death by inhibiting NF\u2212\u03baB signaling","volume":"16","author":"Zhong","year":"2018","journal-title":"Exp Ther Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"148267","DOI":"10.1016\/j.brainres.2023.148267","article-title":"Icariin ameliorates behavioral deficits and neuropathology in a mouse model of multiple sclerosis","volume":"1804","author":"Gao","year":"2023","journal-title":"Brain Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2148-4","article-title":"Genistein: the potential for efficacy in rheumatoid arthritis","volume":"32","author":"Li","year":"2013","journal-title":"Clin Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.37506\/ijfmt.v15i2.14750","article-title":"Environmental factors and protective effects of epigallocatechin-3-gallate to systemic lupus eritematosus: A review study","volume":"15","author":"Mawarti","year":"2021","journal-title":"Indian J Forensic Med Toxicol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2300233","DOI":"10.1002\/adtp.202300233","article-title":"Microneedles loaded with dexamethasone and epigallocatechin-3-gallate reverse the imbalance of subcutaneous immune homeostasis for the treatment of psoriasis","volume":"7","author":"Jia","year":"2024","journal-title":"Advanced Ther"},{"key":"B108","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40001-024-01700-2","article-title":"Role of fenofibrate in multiple sclerosis","volume":"29","author":"Abulaban","year":"2024","journal-title":"Eur J Med Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"121755","DOI":"10.1016\/j.lfs.2023.121755","article-title":"IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy","volume":"326","author":"Park","year":"2023","journal-title":"Life Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0102-6","article-title":"Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation","volume":"49","author":"Calkin","year":"2006","journal-title":"Diabetologia"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5790","article-title":"Peroxisome proliferator-activated receptor \u03b1 agonists as therapy for autoimmune disease","volume":"172","author":"Lovett-Racke","year":"2004","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"103125","DOI":"10.1016\/j.jaut.2023.103125","article-title":"Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease","volume":"140","author":"Kishimoto","year":"2023","journal-title":"J Autoimmunity"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0138","article-title":"Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+ CD25+ FOXP3+ regulatory T-cells","volume":"57","author":"Monti","year":"2008","journal-title":"Diabetes"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078808","article-title":"Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study","volume":"67","author":"Bruyn","year":"2008","journal-title":"Ann rheumatic diseases"},{"key":"B115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13075-023-03181-w","article-title":"Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis","volume":"25","author":"Zhang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"111289","DOI":"10.1016\/j.biopha.2021.111289","article-title":"Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function","volume":"137","author":"Song","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2004.00070.x","article-title":"Efficacy of rapamycin in patient with juvenile rheumatoid arthritis","volume":"18","author":"Foroncewicz","year":"2005","journal-title":"Transplant Int"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sj\u00f6gren\u2019s syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J Controlled release"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S436147","article-title":"The role and mechanism of metformin in inflammatory diseases","volume":"16","author":"Lin","year":"2023","journal-title":"J Inflammation Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S438388","article-title":"Drug repositioning of metformin encapsulated in PLGA combined with photothermal therapy ameliorates rheumatoid arthritis","volume":"18","author":"Kim","year":"2023","journal-title":"Int J Nanomed"},{"key":"B121","doi-asserted-by":"publisher","first-page":"148648","DOI":"10.1016\/j.brainres.2023.148648","article-title":"Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis","volume":"1822","author":"Gilbert","year":"2024","journal-title":"Brain Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"105315","DOI":"10.1016\/j.jddst.2023.105315","article-title":"Colon delivery of resveratrol for the treatment of inflammatory bowel disease","volume":"92","author":"Sardou","year":"2023","journal-title":"J Drug Delivery Sci Technol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/ijms20020398","article-title":"Nanostructured chitosan-based biomaterials for sustained and colon-specific resveratrol release","volume":"20","author":"Iglesias","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa335","article-title":"The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases","volume":"59","author":"Fasano","year":"2020","journal-title":"Rheumatology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aar8278","article-title":"Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11\u2013mediated protection of regulatory T cells","volume":"11","author":"Mondal","year":"2018","journal-title":"Sci Signaling"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew231","article-title":"Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study","volume":"55","author":"Iudici","year":"2016","journal-title":"Rheumatology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"42808","DOI":"10.18632\/oncotarget.17057","article-title":"Mechanism of oxidative stress p38MAPK-SGK1 signaling axis in experimental autoimmune encephalomyelitis (EAE)","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.04.015","article-title":"The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL\/lpr mouse model of systemic lupus","volume":"11","author":"Jin","year":"2011","journal-title":"Int immunopharmacol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/cei\/uxae056","article-title":"Inhibition of the TIM-1 and-3 signaling pathway ameliorates disease in a murine model of rheumatoid arthritis","volume":"218","author":"Nozaki","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13148","article-title":"Tim-3 suppresses autoimmune hepatitis via the p38\/MKP-1 pathway in Th17 cells","volume":"11","author":"Wu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13253","article-title":"JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus","volume":"26","author":"Klaeschen","year":"2017","journal-title":"Exp Dermatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"283617","DOI":"10.1155\/2014\/283617","article-title":"JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis","volume":"2014","author":"Hsu","year":"2014","journal-title":"J Immunol Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650708","article-title":"Baricitinib ameliorates experimental autoimmune encephalomyelitis by modulating the Janus kinase\/signal transducer and activator of transcription signaling pathway","volume":"12","author":"Dang","year":"2021","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14403","article-title":"A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1\/JAK2 inhibitor, in patients with moderate-to-severe psoriasis","volume":"174","author":"Papp","year":"2016","journal-title":"Br J Dermatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2285784","article-title":"Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis\u2013a review of current evidence","volume":"27","author":"Staniszewska","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13414","article-title":"CDK 7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-\u03baB activation and IL-1\u03b2\/IL-6 secretion","volume":"22","author":"Hong","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-014-0305-6","article-title":"Selective inhibition of CDK7 ameliorates experimental arthritis in mice","volume":"15","author":"Xia","year":"2015","journal-title":"Clin Exp Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS J"},{"key":"B139","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2141.2008.07433.x","article-title":"Dasatinib inhibits the proliferation and function of CD4+ CD25+ regulatory T cells","volume":"144","author":"Fei","year":"2009","journal-title":"Br J haematol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14627","article-title":"Dasatinib, a selective tyrosine kinase inhibitor, prevents joint destruction in rheumatoid arthritis animal model","volume":"26","author":"Min","year":"2023","journal-title":"Int J Rheumatic Diseases"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1028074","article-title":"Therapeutic effects of dasatinib in mouse model of multiple sclerosis","volume":"37","author":"Azizi","year":"2015","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210804091548","article-title":"Flavonoids and PI3K\/Akt\/mTOR signaling cascade: a potential crosstalk in anticancer treatment","volume":"28","author":"ul Islam","year":"2021","journal-title":"Curr Medicinal Chem"},{"key":"B143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/08916934.2018.1442828","article-title":"Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis","volume":"51","author":"Dos Santos","year":"2018","journal-title":"Autoimmunity"},{"key":"B144","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12979-024-00474-9","article-title":"Quercetin ameliorates lupus symptoms by promoting the apoptosis of senescent Tfh cells via the Bcl-2 pathway","volume":"21","author":"Xiong","year":"2024","journal-title":"Immun Ageing"},{"key":"B145","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/ncomms11190","article-title":"Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL","volume":"7","author":"Yosef","year":"2016","journal-title":"Nat Commun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1475828","article-title":"Hsp90 inhibitors as senolytic drugs to extend healthy aging","volume":"17","author":"Fuhrmann-Stroissnigg","year":"2018","journal-title":"Cell Cycle"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00273.x","article-title":"Heat shock proteins: essential proteins for apoptosis regulation","volume":"12","author":"Lanneau","year":"2008","journal-title":"J Cell Mol Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90135-8","article-title":"Heat shock proteins in multiple sclerosis and other autoimmune diseases","volume":"14","author":"Georgopoulos","year":"1993","journal-title":"Immunol Today"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1042\/cs0840381","article-title":"Antibodies to human recombinant lipocortin-L in inflammatory bowel disease","volume":"84","author":"Stevens","year":"1993","journal-title":"Clin Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-006-0609-1","article-title":"The expression of molecular chaperone HSP90 and IL-6 in patients with systemic lupus erythematosus","volume":"26","author":"Hu","year":"2006","journal-title":"J Huazhong Univ Sci Technol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.640","article-title":"Senescence and aging: the critical roles of p53","volume":"32","author":"Rufini","year":"2013","journal-title":"Oncogene"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2014012193","article-title":"Role of p53 in systemic autoimmune diseases","volume":"34","author":"Takatori","year":"2014","journal-title":"Crit Reviews\u2122 Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199906)42:6<1088::AID-ANR4>3.0.CO;2-E","article-title":"Dominant-negative p53 mutations in rheumatoid arthritis","volume":"42","author":"Han","year":"1999","journal-title":"Arthritis Rheumatism"},{"key":"B154","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.18632\/aging.204187","article-title":"Nutlin-3a for age-related macular degeneration","volume":"14","author":"Chung","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B155","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/molecules27030738","article-title":"Fisetin as a senotherapeutic agent: biopharmaceutical properties and crosstalk between cell senescence and neuroprotection","volume":"27","author":"Elsallabi","year":"2022","journal-title":"Molecules"},{"key":"B156","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainresbull.2017.09.007","article-title":"The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation","volume":"135","author":"Hashimoto","year":"2017","journal-title":"Brain Res bulletin"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828f5198","article-title":"A pilot study to evaluate the safety and efficacy of an oral dose of (\u2013)-epigallocatechin-3-gallate\u2013rich Polyphenon E in patients with mild to moderate ulcerative colitis","volume":"19","author":"Dryden","year":"2013","journal-title":"Inflammatory bowel diseases"},{"key":"B158","doi-asserted-by":"publisher","first-page":"546753","DOI":"10.1155\/2008\/546753","article-title":"PPAR alpha regulation of the immune response and autoimmune encephalomyelitis","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031151","article-title":"CDK6-Dependent, CDK4-independent synovial hyperplasia in arthritic mice and tumor necrosis factor-\u03b1-induced proliferation of synovial fibroblasts","volume":"26","author":"Komatsu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2285784","article-title":"Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis\u2013a review of current evidence.","volume":"27","author":"Staniszewska","year":"2023","journal-title":"Expert Opin Ther Targets."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-213-44046","article-title":"p21\u2014negative regulator of the cell cycle","volume":"213","author":"Gartel","year":"1996","journal-title":"Proc Soc Exp Biol Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.07.022","article-title":"Involvement of the p53\/p21 complex in p53-dependent gene expression","volume":"621","author":"Kim","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.2.838","article-title":"IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts","volume":"170","author":"Perlman","year":"2003","journal-title":"J Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae357","article-title":"A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4\/6 inhibitor, TCK-276, in patients with active rheumatoid arthritis","volume":"64","author":"Tasaki","year":"2024","journal-title":"Rheumatology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.jid.2021.04.018","article-title":"Cyclin-dependent kinase 7 promotes Th17\/Th1 cell differentiation in psoriasis by modulating glycolytic metabolism","volume":"141","author":"Lin","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838761","article-title":"Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells","volume":"38","author":"Schmitz","year":"2008","journal-title":"Eur J Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2054636","article-title":"Cell senescence, rapamycin and hyperfunction theory of aging","volume":"21","author":"Blagosklonny","year":"2022","journal-title":"Cell Cycle"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2023.2232101","article-title":"mTORC1 inhibition may improve T lymphocytes affected by aging","volume":"45","author":"Asghari","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.exger.2017.01.026","article-title":"Rapamycin and the inhibition of the secretory phenotype","volume":"94","author":"Wang","year":"2017","journal-title":"Exp gerontol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2022.03.004","article-title":"Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis","volume":"245","author":"Caza","year":"2022","journal-title":"Trans Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci letters"},{"key":"B173","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/biomedicines11030949","article-title":"Rapamycin treatment alleviates chronic GVHD-induced lupus nephritis in mice by recovering IL-2 production and regulatory T cells while inhibiting effector T cells activation","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomedicines"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/rai2.12120","article-title":"Rapamycin suppresses rheumatoid arthritis fibroblast synovial cell proliferation and induces apoptosis via the AKT\/mTORC1 pathway","volume":"4","author":"Zhang","year":"2024","journal-title":"Rheumatol Autoimmunity"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13663","article-title":"Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis","volume":"206","author":"Tang","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease","volume":"37","author":"Kim","year":"2021","journal-title":"Korean J Internal Med"},{"key":"B177","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.3390\/ijms21175957","article-title":"Metformin as a potential agent in the treatment of multiple sclerosis","volume":"21","author":"Dziedzic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726490","article-title":"Efficacy and safety of metformin use in rheumatoid arthritis: a randomized controlled study","volume":"12","author":"Gharib","year":"2021","journal-title":"Front\u00a0Pharmacol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0070","article-title":"Redox homeostasis involvement in the pharmacological effects of metformin in systemic lupus erythematosus","volume":"36","author":"Teng","year":"2022","journal-title":"Antioxidants Redox Signaling"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am J Physiology-Cell Physiol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1396031","article-title":"Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota","volume":"15","author":"Wang","year":"2024","journal-title":"Front Microbiol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/nu9121306","article-title":"Resveratrol role in autoimmune disease\u2014a mini-review","volume":"9","author":"Oliveira","year":"2017","journal-title":"Nutrients"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00410-5","article-title":"Biological effects of resveratrol","volume":"66","author":"Fr\u00e9mont","year":"2000","journal-title":"Life Sci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.935172","article-title":"Resveratrol attenuates rheumatoid arthritis induce neutrophil extracellular traps via TLR-4 mediated inflammation in C57BL\/6 mice","volume":"73","author":"Zequan","year":"2024","journal-title":"Physiol Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-023-00959-z","article-title":"Neurobehavioral, biochemical and histological assessment of the effects of resveratrol on cuprizone-induced demyelination in mice: role of autophagy modulation","volume":"79","author":"Samy","year":"2023","journal-title":"J Physiol Biochem"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2174\/1872214809666150806105737","article-title":"Resveratrol pretreatment ameliorates TNBS colitis in rats","volume":"9","author":"Yildiz","year":"2015","journal-title":"Recent Patents Endocrine Metab Immune Drug Discovery"},{"key":"B187","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intimp.2011.11.021","article-title":"Aspirin and immune system","volume":"12","author":"Hussain","year":"2012","journal-title":"Int immunopharmacol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K","article-title":"Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal\u2013regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis Rheumatism"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.10.5342","article-title":"p38 mitogen-activated protein kinase is activated and linked to TNF-\u03b1 signaling in inflammatory bowel disease","volume":"168","author":"Waetzig","year":"2002","journal-title":"J Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.10.019","article-title":"p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris","volume":"12","author":"Mavropoulos","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B191","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal transduction targeted Ther"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.05.015","article-title":"Perspective: Targeting the JAK\/STAT pathway to fight age-related dysfunction","volume":"111","author":"Xu","year":"2016","journal-title":"Pharmacol Res"},{"key":"B193","doi-asserted-by":"publisher","first-page":"119395","DOI":"10.1016\/j.lfs.2021.119395","article-title":"Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS)","volume":"276","author":"Hosseini","year":"2021","journal-title":"Life Sci"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.08.038","article-title":"Treatment of cutaneous lupus with topical ruxolitinib cream","volume":"28","author":"Park","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B195","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann rheumatic diseases"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.05.010","article-title":"Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases","volume":"41","author":"Hafeez","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.133","article-title":"Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity","volume":"15","author":"Wu","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"New Engl J Med"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy267","article-title":"B-cell therapy in lupus nephritis: an overview","volume":"34","author":"Almaani","year":"2019","journal-title":"Nephrol Dialysis Transplantation"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead253","article-title":"Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials","volume":"63","author":"Gomez","year":"2024","journal-title":"Rheumatology"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1159794","article-title":"Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review","volume":"10","author":"Sans-Pola","year":"2023","journal-title":"Front Med"},{"key":"B202","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2217\/17460816.1.3.293","article-title":"Rituximab: B-cell depletion therapy for the treatment of rheumatoid arthritis","volume":"1","author":"Dass","year":"2006","journal-title":"Int J Clin Rheumatol"},{"key":"B203","volume-title":"Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis: A Review of the Clinical effectiveness, Cost-effectiveness, and Guidelines","author":"Ho","year":"2018"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-011620-034148","article-title":"B cell immunosenescence","volume":"36","author":"Frasca","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.autrev.2011.06.010","article-title":"B-cells and their targeting in rheumatoid arthritis\u2014current concepts and future perspectives","volume":"11","author":"Nakken","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51732","article-title":"Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review","volume":"10","author":"Montalban","year":"2023","journal-title":"Ann Clin Trans neurol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151522","article-title":"Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial","volume":"70","author":"Taylor","year":"2011","journal-title":"Ann rheumatic diseases"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12780","article-title":"Successful treatment of multiple sclerosis with refractory rheumatoid arthritis using ofatumumab: A case report","volume":"15","author":"Hara","year":"2024","journal-title":"Clin Exp Neuroimmunol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S6840","article-title":"Ofatumumab: a novel monoclonal anti-CD20 antibody","volume":"3","author":"Lin","year":"2010","journal-title":"Pharmacogenomics personalized Med"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1002\/art.42734","article-title":"Kidney outcomes and preservation of kidney function with obinutuzumab in patients with lupus nephritis: A post hoc analysis of the NOBILITY Trial","volume":"76","author":"Rovin","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S388410","article-title":"Evaluating the therapeutic potential of ublituximab in the treatment of MS: design, development and place in therapy","volume":"18","author":"Martin","year":"2024","journal-title":"Drug Design Dev Ther"},{"key":"B212","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.3390\/jcm12144848","article-title":"Efficacy and safety of new B cell-targeted biologic agent for the treatment of systemic lupus erythematosus: A systematic review and meta-analysis","volume":"12","author":"G\u00f3mez-Urquiza","year":"2023","journal-title":"J Clin Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098315","article-title":"Anti-CD22\/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus","volume":"9","author":"Rossi","year":"2014","journal-title":"PloS One"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00433","article-title":"Systematic review of safety and efficacy of atacicept in treating immune-mediated disorders","volume":"11","author":"Kaegi","year":"2020","journal-title":"Front Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int"},{"key":"B216","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/bjd\/ljac040","article-title":"Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials","volume":"188","author":"Langley","year":"2023","journal-title":"Br J Dermatol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"2411849","DOI":"10.1080\/09546634.2024.2411849","article-title":"Superior effect of adalimumab versus secukinumab on ultrasound-confirmed synovitis in psoriatic arthritis: comprehensive evidence from musculoskeletal ultrasound and clinical assessments","volume":"35","author":"Wang","year":"2024","journal-title":"J Dermatol Treat"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2022.2028364","article-title":"Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial","volume":"52","author":"Ruwaard","year":"2023","journal-title":"Scandinavian J Rheumatol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"2249145","DOI":"10.1080\/09546634.2023.2249145","article-title":"Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis","volume":"34","author":"Li","year":"2023","journal-title":"J Dermatol Treat"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05483-3","article-title":"Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: A case-based review","volume":"44","author":"Kounatidis","year":"2024","journal-title":"Rheumatol Int"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2210","article-title":"Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis","volume":"7","author":"Azadbakht","year":"2024","journal-title":"Health Sci Rep"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1243468","article-title":"Anti TNF-\u03b1 therapy for ulcerative colitis: current status and prospects for the future","volume":"13","author":"Pugliese","year":"2017","journal-title":"Expert\u00a0Rev Clin Immunol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.2174\/0115733971289295240223095751","article-title":"An overview of adalimumab therapy for ankylosing spondylitis","volume":"20","author":"Sukhanova","year":"2024","journal-title":"Curr\u00a0Rheumatol Rev"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11493","article-title":"Randomized trial of tocilizumab in the treatment of refractory adult polymyositis and dermatomyositis","volume":"4","author":"Oddis","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00265-5","article-title":"Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study","volume":"5","author":"Unizony","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2058555","article-title":"Tocilizumab in recalcitrant bilateral scleritis in a case of relapsing polychondritis: A 17-year follow up","volume":"31","author":"Doctor","year":"2023","journal-title":"Ocular Immunol Inflammation"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1097\/GH9.0000000000000470","article-title":"Successfully treated refractory Sj\u00f6gren\u2019s syndrome myelopathy with tocilizumab; case report","volume":"7","author":"Shahada","year":"2024","journal-title":"IJS Global Health"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae711","article-title":"The efficacy and safety of intravenous tocilizumab to treat Graves\u2019 ophthalmopathy: A systematic review and single-arm meta-analysis","volume":"110","author":"Sun","year":"2024","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2101","article-title":"Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis","volume":"31","author":"\u00d6zdemir","year":"2020","journal-title":"Ann Oncol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1182\/blood-2021-153437","article-title":"Bortezomib for the management of relapsed or refractory warm autoimmune hemolytic anemia: A scoping review","volume":"138","author":"Johnson","year":"2021","journal-title":"Blood"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231153863","article-title":"Deucravacitinib: the first FDA-approved oral TYK2 inhibitor for moderate to severe plaque psoriasis","volume":"58","author":"Truong","year":"2024","journal-title":"Ann\u00a0Pharmacother"},{"key":"B232","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/lupus-2024-el.159","article-title":"P105 NEX-T CD19 chimeric antigen receptor (CAR) T-cell therapy CC-97540 (BMS-986353): Preclinical and translational evidence of deep B-cell depletion suitable for study in severe refractory autoimmune diseases","author":"Schett","year":"2024","journal-title":"Arch Dis childhood"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204169","article-title":"A Study of Kyv-101, a CD19 CAR T cell therapy, in participants with treatment refractory progressive multiple sclerosis","volume":"144","author":"Seshadri","year":"2024","journal-title":"Blood"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S438388","article-title":"Drug repositioning of metformin encapsulated in PLGA combined with photothermal therapy ameliorates rheumatoid arthritis.","volume":"2023","author":"Kim","year":"2025","journal-title":"Int J Nanomed."},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210631","article-title":"Design of KYSA-8, A phase 2, open-label, multicenter study of KYV-101, an autologous fully human anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in treatment refractory stiff-person syndrome (P2-8.018)","author":"Piquet","year":"2025","journal-title":"Neurology"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.19.585779","article-title":"Senolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitness","author":"Eskiocak","year":"2024","journal-title":"bioRxiv"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00560-5","article-title":"Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction","volume":"4","author":"Amor","year":"2024","journal-title":"Nat Aging"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:29:34Z","timestamp":1754544574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":239,"alternative-id":["10.3389\/fimmu.2025.1596686"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1596686","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1596686"}}